Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
PURPOSE: This is a systematic review to evaluate the impact of various follow-up intensities and strategies on the outcome of patients after curative surgery for colorectal cancer. METHODS: All randomized trials up to January 2007, comparing different follow-up intensities and strategies, were retrieved. Meta-analysis was performed by using the Forest plot review. RESULTS: Eight randomized, clinical trials with 2,923 patients with colorectal cancer undergoing curative resection were reviewed. There was a significant reduction in overall mortality in patients having intensive follow-up (intensive vs. less intensive follow-up: 21.8 vs. 25.7 percent; P = 0.01). Regular surveillance with serum carcinoembryonic antigen (P = 0.0002) and colonoscopy (P = 0.04) demonstrated a significant impact on overall mortality. However, cancer-related mortality did not show any significant difference. There was no significant difference in all-site recurrence and in local or distant metastasis. Detection of isolated local and hepatic recurrences was similar. Intensive follow-up detected asymptomatic recurrence more frequently (18.9 vs. 6.3 percent; P < 0.00001) and 5.91 months earlier than less intensive follow-up protocol; these were demonstrated with all investigation strategies used. Intensive surveillance program detected recurrences that were significantly more amenable to surgical reresection (10.7 vs. 5.7 percent; P = 0.0002). The chance of curative reresection were significantly better with more intensive follow-up (24.3 vs. 9.9 percent; P = 0.0001), independent of the investigation strategies used. CONCLUSIONS: Intensive follow-up after curative resection of colorectal cancer improved overall survival and reresection rate for recurrent disease. However, the cancer-related mortality was not improved and the survival benefit was not related to earlier detection and treatment of recurrent disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Meta-analyses of RCTs conducted in Europe and the United States have shown that surveillance after curative surgical resection of colorectal cancer contributes to improving the resection rate of recurrent tumors and to improving the prognosis [127–131]”
From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [131]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Renehan, A. G., Egger, M., Saunders, M. P., & O'Dwyer, S. T. (2002) · BMJ · doi:10.1136/bmj.324.7341.813 · Cited by 651
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
Figueredo, A., Rumble, R. B., Maroun, J., Earle, C. C., Cummings, B., McLeod, R., Zuraw, L., Zwaal, C., & the members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care (2003) · BMC Cancer · doi:10.1186/1471-2407-3-26 · Cited by 392 · cited 1×
“73 Adjusted net cost per patient * all site surveillance U2479 (US$4940) extramural detection targeted surveillance U2529 (US$5040) Adjusted net cost each life year gained * all site surveillance U3402 (US$6779) extramural detection targeted surveillance U3077 (US$6132) Figueredo et al.(4) (2003) 5 Year Mortality RR 0.”
BackgroundSchoemaker, D., Black, R., Giles, L., & Toouli, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70626-2 · Cited by 386
(2012) · Hepatogastroenterology · doi:10.5754/hge11937 · Cited by 381
Research works printed but not linked: 4
- Wattchow DA, Weller D, Pilotto L, et al. Randomized controlled trial (RCT) comparing hospital and general practice based follow-up of patients with colon cancer. ANZ J Surg 2002;72(Suppl):A22
- Review Manager. RevMan user guideline, [computer program] version 4.2 for windows. Oxford, England: The Cochrane Collaboration, 2002.
- Lennon T, Houghton J, Northover J. What is the value of clinical follow-up for colorectal cancer patients? The experience of the CRC/NIH CEA Second Look Trial. Nottingham, England International Colorectal Cancer Symposium 1995. Available at: http://www.york.ac.uk/inst/crd/ehc36.pdf . Accessed May 1, 2005
- Schorr M, Siebeck M, Zoller WC. Colorectal cancer: a rational follow up program adapted to patient’s individual risk of recurrence. Z Gastroenterol 1997;35:1019-7
Cited by
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467
“Meta-analyses of RCTs conducted in Europe and the United States have shown that surveillance after curative surgical resection of colorectal cancer contributes to improving the resection rate of recurrent tumors and to improving the prognosis [70–74] (CQ-19).”
BackgroundEarly colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Labianca, R., Nordlinger, B., Beretta, G. D., Mosconi, S., Mandalà, M., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt354 · Cited by 1,404
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Itabashi, M., Shimada, Y., Tanaka, S., Ito, Y., Ajioka, Y., Hamaguchi, T., Hyodo, I., Igarashi, M., et al. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0315-2 · Cited by 700
Metadata
- Authors
- Tjandra, J. J., & Chan, M. K. Y.
- Affiliations
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Venue
- Diseases of the Colon & Rectum
- Published
- 2007-11
- Volume
- 50
- Issue
- 11
- Pages
- 1783-1799
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W2053700486
- Cited by
- 342
- References
- 59
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 33 · 2020: 22 · 2019: 25 · 2018: 23 · 2017: 24 · 2016: 21 · 2015: 25 · 2014: 21 · 2013: 24 · 2012: 25
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diseases of the Colon & Rectum (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- colorectal cancer, curative resection, postoperative follow-up, surveillance intensity, carcinoembryonic antigen, colonoscopy, recurrence detection, overall survival, cancer mortality, re-irradiation, hepatic recurrence
- MeSH terms
- Carcinoembryonic Antigen, Colonoscopy, Continuity of Patient Care, Humans, Neoplasm Recurrence, Local, Outcome and Process Assessment, Health Care, Quality of Life, Reoperation, Colorectal Neoplasms, Survival Analysis, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis. https://app.cochat.ai/papers/10.1007/s10350-007-9030-5
- The paper
- Tjandra, J. J., & Chan, M. K. Y. (2007). Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis. Diseases of the Colon & Rectum. https://doi.org/10.1007/s10350-007-9030-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.